Autolus Therapeutics plc Stock: price and insider trades · United States
Autolus Therapeutics plc: what insiders have been doing
Autolus Therapeutics plc is a listed company based in United Kingdom, founded in 2014. Its insiders report their share dealings to SEC (Form 4). 1 insider has disclosed 2 filings since 8 November 2025.
There is no open-market purchase to report; the filings show 1 sale worth €14k by 1 insider. At €14k, the sale published on 3 September 2026 by Piccina Cintia is the largest of the period (0.0037% of market cap).
Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For context, the typical company on the same exchange (median of 5,813 companies) published 19 filings over the same period, against 2 filings here. Our records for Autolus Therapeutics plc go back to 2026, with no purchases and 1 sale on the open market in total.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Key facts
Headquarters: United Kingdom · Founded: 2014
Source: Wikidata (CC0).
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Autolus Therapeutics plc Strong Buy (bullish), based on 8 analysts. Average price target: US$8.73.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 20,000 shares@ US$2.3574.9% of flowAmerican Depositary SharesSEC:0001730463-26-000131:0
- 6,713 shares@ US$2.33625.1% of flowAmerican Depositary SharesSEC:0001730463-26-000131:1
2 of 2 declarations
About Autolus Therapeutics plc
Autolus Therapeutics plc is a biopharmaceutical company focused on developing cell therapies for cancer treatment. It is listed on NASDAQ under the ticker symbol AUTL.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
